Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Retained Earnings (2024 - 2025)

BioAge Labs (BIOA) has disclosed Retained Earnings for 2 consecutive years, with -$333.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 136188.16% to -$333.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$333.4 million through Dec 2025, down 136188.16% year-over-year, with the annual reading at -$333.4 million for FY2025, 136188.16% down from the prior year.
  • Retained Earnings hit -$333.4 million in Q4 2025 for BioAge Labs, down from $275000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $275000.0 in Q3 2025 to a low of -$333.4 million in Q4 2025.